Orbimed Advisors reported a 17.4% stake in Q32 Bio QTTB · 4,127,987 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 17.4%
Last report: 13.3% · filed 26/05/06
Shares held: 4,127,987 sh
Class: COMMON STOCK
Stock: Q32 Bio QTTB
Holder: Orbimed Advisors
Event date: 26/05/28
Filed: 26/06/01

17.4% stake · +4.1pp from the last report

Stake: 17.4%
Last report: 13.3%
Since last report: +4.1pp

Q32 Bio trades, last 26 weeks

What else happened in Q32 Bio around then

Filed or reported within 30 days of the trade day · 04/28~06/27

Orbimed Advisors's other 5% stake reports

Orbimed Advisors
5% stakeElectra Therapeutics
5% stake
Electra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
Orbimed Advisors
5% stakeBraveheart Bio
5% stake
Braveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stake
BlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stake
Whitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14